CALGARY, Alberta, Oct. 02, 2019 (GLOBE NEWSWIRE) -- AIM & TSX: “TGL” & NASDAQ: “TGA” NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer) 1a. Identity of the issuer or the underlying issuer of existing shares to which voting …
Pulse Oximeter Market Research Report: By Type (Fingertip, Table-Top, Wrist-Worn, Hand-Held, Earlobe, Forehead, Palm/Foot, Nose), Sensor Type (Reusable, Disposable), Patient Type (Neonatal, Pediatric, Adult), End User (Hospitals, Clinics & Healthcare …
CGG Delivers Advanced 4D Images for BP Angola Survey in 8 Weeks Paris, France – October 2, 2019 CGG Subsurface Imaging, part of CGG’s Geoscience division, has delivered state-of-the-art broadband 4D seismic results ahead of schedule from BP Angola’s latest …
Press Release Top Line Results from Glaucoma Dolomites Phase 2 Trial Show Nicox’s NCX 470 Meets Primary Endpoint and Demonstrates Statistical Superiority vs Latanoprost NCX 470 met the primary endpoint of non-inferiority and also demonstrated …
Novadip Biosciences Presents Clinical Case Study on Next Generation Tissue Regeneration Therapy for Critical Size Bone Reconstruction at EORS Conference Study highlights potential benefit in rare pediatric orthopedic disorder Mont …
Birmingham, AL, Oct. 02, 2019 (GLOBE NEWSWIRE) -- According to researchers, shedding just 10 percent of one’s body weight can reverse type 2 diabetes or send it into remission. Moderate weight loss for those who are overweight also has positive impacts on …
Poster presentations to highlight allogeneic and autologous NKG2D-based CAR-T therapies for the treatment of advanced metastatic colorectal (mCRC) cancers MONT-SAINT-GUIBERT, Belgium, Oct. 02, 2019 (GLOBE NEWSWIRE) -- Celyad (Euronext Brussels and Paris, …
MONT-SAINT-GUIBERT, Belgium, Oct. 02, 2019 (GLOBE NEWSWIRE) -- Celyad (Euronext Brussels and Paris, and Nasdaq: CYAD), a clinical-stage biopharmaceutical company focused on the development of CAR-T cell-based therapies, today announced that management …
VANCOUVER, Washington, Oct. 01, 2019 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company”), a late stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic …
SANTA CLARA, Calif., Oct. 01, 2019 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today by Landec Corporation (Nasdaq: LNDC) please note that in question #4 in the Questions & Answers section, the phrasing 'fiscal 2019' …
NEW YORK, Oct. 01, 2019 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Cadence Bancorporation (“Cadance” or the “Company”) (NYSE:CADE). Such investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw. …
NEW YORK, Oct. 01, 2019 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Farfetch Limited (“Farfetch” or the “Company”) (NYSE: FTCH). Such investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com …
NEW YORK, Oct. 01, 2019 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of GreenLane Holdings, Inc. (“Greenlane” or the “Company”) (NASDAQ: GNLN). Such investors are advised to contact Robert S. Willoughby at rswilloughby@ …
NEW YORK, Oct. 01, 2019 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of ProPetro Holdings Corp. (“ProPetro” or the “Company”) (NYSE: PUMP). Such investors are advised to contact Robert S. Willoughby at rswilloughby@ …
NEW YORK, Oct. 01, 2019 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of MacroGenics, Inc. (“MacroGenics” or the “Company”) (NASDAQ: MGNX). Such investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw …
NEW YORK, Oct. 01, 2019 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Nektar Therapeutics (“Valaris” or the “Company”) (NASDAQ: NKTR). Such investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw …
NEW YORK, Oct. 01, 2019 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of SAExploration Holdings, Inc. (“SAExploration” or the “Company”) (NASDAQ: SAEX). Such investors are advised to contact Robert S. Willoughby at …
SAN FRANCISCO, Oct. 01, 2019 (GLOBE NEWSWIRE) -- Hagens Berman notifies PUMP investors of a securities fraud lawsuit filed against ProPetro Holding Corp. (PUMP). CLASS PERIOD: Mar. 17, 2017 – Aug. 8, 2019 LEAD PLAINTIFF DEADLINE: Nov. 15, 2019 Email: PUMP@ …
NEW YORK, Oct. 01, 2019 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Pluralsight, Inc. (“Pluralsight” or the “Company”) (NASDAQ: PS). Such investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw. …
SAN FRANCISCO, Oct. 01, 2019 (GLOBE NEWSWIRE) -- Hagens Berman reminds investors in Myriad Genetics, Inc. (NASDAQ: MYGN) of the pending securities class action and urges MYGN investors who have suffered losses in excess of $50,000 to contact the firm. …
